To Get Help Now
Click Here
 
Today's Date:

Merck Marketing Under Investigation

AddThis Social Bookmark Button

The Justice Department has issued a subpoena requesting that Merck supply information about marketing and selling activities for the antibiotic Avelox, and the heart drug Integrilin, from January 2003 to June 2010. Merck said in a filing with the Securities and Exchange Commission that the subpoena was part of a civil federal health-care investigation, and that they are complying.

Merck has reported that the Justice Department has issued a civil investigation into Inspire Pharmaceuticals, which Merck acquired in May, over allegations that the company marketed AzaSite for uses not approved by the FDA, which caused false claims to be submitted to federal health-care programs. AzaSite is a antibiotic used to treat bacterial conjunctivitis (eye infection).

Merck also reported that it has reached a $49.5 million agreement in principal with plaintiffs of Vioxx related lawsuits filed by former and current Merck employees who participated in Merck retirement plans and alleged that Merck and specific current and former officers and directors breached their fiduciary duties through false and misleading statements about Vioxx, the Wall Street Journal reported.

 

breakinglawsuitnews.com disclaimer: This article: Merck Marketing Under Investigation was posted on Thursday, November 10th, 2011 at 11:27 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.